Indeed, in urothelial transitional cell cancer (Bilim et al, 1998), oesophagus cancer (Hsia et al, 2001) and prostate cancer (Bauer et al, 1996) cases with Bcl-2 positivity represent poor prognosis. This evidence concerns the gene BCL2 and prostate carcinoma.